← Leaderboards
Dipali Sharma
Emory University
$3,976,187
Attributed
$4,100,877
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $531.7K · FY2009–24$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,100,877 · 4
By mechanism
R01$3,713,292 · 3
R21$387,585 · 1
Top collaborators
- Dayanidhi Raman1 shared
Most similar at Emory University
Same institution · by research overlap
- Jack L Arbiser$5,737,275
- Carmen Joseph Marsit$32,367,089
- Aftab A. Ansari$22,344,206
- Haian Fu$16,783,892
- Renee D Read$5,379,597
Others in their field
Top investigators on “Malignant Breast Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$347,312,063
- Norman Wolmark · Nsabp Foundation, Inc.$122,067,540
- Walter John Curran · Thomas Jefferson University$97,002,422
- Monica M Bertagnolli · Strang Cancer Prevention Center$84,975,759
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$68,847,428
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$60,763,376
Research focus
Malignant Breast NeoplasmWomanNeoplasm MetastasisTumor ProgressionIn VivoMolecularBaseMigrationSignal TransductionPre-ClinicalGrowthExhibitsMammary NeoplasmsBreast Cancer CellOncogenicTumorSamplingStk11 GeneBiologicalMediatingMalignant NeoplasmsMortality Vital StatisticsDeath RateAdipocytes
Grant awards (14)
Targeting eIF4A1 in drug-resistant breast cancer stem-like cells$249,381
R01 · FY2024 · CA
Evaluation of molecular determinants of racial disparity in triple-negative breast cancer$374,578
R01 · FY2021 · CA · contact PI
Evaluation of molecular determinants of racial disparity in triple-negative breast cancer$374,578
R01 · FY2020 · CA · contact PI
Evaluation of molecular determinants of racial disparity in triple-negative breast cancer$363,340
R01 · FY2019 · CA · contact PI
Evaluation of molecular determinants of racial disparity in triple-negative breast cancer$374,435
R01 · FY2018 · CA · contact PI
Evaluation of molecular determinants of racial disparity in triple-negative breast cancer$373,721
R01 · FY2017 · CA · contact PI
Inhibition of leptin-signaling axis in breast cancer by BITC$176,175
R21 · FY2015 · CA · contact PI
Role of adipocytokines, leptin and adiponectin in breast carcinogenesis$320,295
R01 · FY2014 · CA · contact PI
Inhibition of leptin-signaling axis in breast cancer by BITC$211,410
R21 · FY2014 · CA · contact PI
Role of adipocytokines, leptin and adiponectin in breast carcinogenesis$309,592
R01 · FY2013 · CA · contact PI
Role of adipocytokines, leptin and adiponectin in breast carcinogenesis$1
R01 · FY2012 · CA · contact PI
Role of adipocytokines, leptin and adiponectin in breast carcinogenesis$330,121
R01 · FY2011 · CA · contact PI
Role of adipocytokines, leptin and adiponectin in breast carcinogenesis$321,625
R01 · FY2010 · CA · contact PI
Role of adipocytokines, leptin and adiponectin in breast carcinogenesis$321,625
R01 · FY2009 · CA · contact PI